Controversy of oral hypoglycemic agents in type 2 diabetes mellitus: Novel move towards combination therapies.
AIM: As diabetes mellitus is multi-factorial disease, use of several oral hypoglycemic agents (OHAs) is the main stay of pharmacological treatment. The treatment has become more challenging and controversial as OHAs are heterogeneous in their mode of acti..... Read More